🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Biomolecular Characteristics of Reminder-Focused Positive-Psychiatry

RecruitingNAAges 11 Years - 15 YearsAllUniversity of California, Los Angeles
NCT04529031 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Objective: Posttraumatic stress disorder (PTSD) is a prevalent neuropsychiatric disorder in children and is associated with increased neurovascular inflammation, suicidality, adulthood mental health disorder, and major adverse events. Reminder focused positive psychiatry (RFPP) has been shown as well tolerated feasible trauma focused intervention that is associated with improved core PTSD symptoms, decreased severity of reactivity to PTSD trauma reminders, and increased vascular function. This study evaluates the clinical and biomolecular characteristics of RFPP in adolescents with PTSD. Research Design/Overall Impact: After obtaining parents' informed consent and adolescent's assent, 60 adolescents aged 11-15 years old with PTSD, and free of known medical and other major psychiatric disorders will be recruited from the pool of eligible adolescents at Olive View UCLA Pediatrics Clinics

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Boy/Girl with documented PTSD, * aged 11- 15 years old, * able to read/write in English Exclusion Criteria: * presence of intellectual disabilities, * presence of psychotic or self-injurious behavior, * presence of seizure disorder, * presence of language disorder, * presence of eye disorders, * presence of other neurodevelopmental disorders, * presence of diagnosis of substance use disorder.
💊

What it tests

  • Reminder Focused Positive Psychiatry
  • attentional control condition (group process)
📍

Where

1 site
UCLA
Los Angeles, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy